Podcast
What The FDA's Dispenser Warning Letter Means For DSCSA Compliance (Podcast)
Following the FDA's warning letter to a medical spa over Botox products, this episode examines what the enforcement action reveals about the agency's compliance expectations under the Drug Supply Chain Security Act. The discussion explores potential signals about FDA priorities and outlines practical steps dispensers should take to mitigate risk and maintain compliance.
K&L Gates